77 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33479510 | The role of orphan receptor GPR139 in neuropsychiatric behavior. | 2022 Mar | 2 |
2 | 33645311 | Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice. | 2021 Apr | 1 |
3 | 34216648 | Involvement of dopamine D2 and glutamate NMDA receptors in the antidepressant-like effect of amantadine in mice. | 2021 Sep 10 | 1 |
4 | 30417675 | α-Mangostin exhibits antidepressant-like effects mediated by the modification of GABAergic, serotonergic and dopaminergic systems. | 2020 Mar | 1 |
5 | 32175760 | Dissociating the effects of dopamine D2 receptors on effort-based versus value-based decision making using a novel behavioral approach. | 2020 Apr | 1 |
6 | 32919985 | Possible involvement of D2/D3 receptor activation in ischemic preconditioning mediated protection of the brain. | 2020 Dec 1 | 1 |
7 | 33009372 | The mammalian target of rapamycin (mTOR) kinase mediates haloperidol-induced cataleptic behavior. | 2020 Oct 2 | 3 |
8 | 30597182 | Aripiprazole and haloperidol protect neurite lesions via reducing excessive D2R-DISC1 complex formation. | 2019 Jun 8 | 1 |
9 | 31034808 | Gnal haploinsufficiency causes genomic instability and increased sensitivity to haloperidol. | 2019 Aug | 1 |
10 | 31233824 | D2 receptor-mediated miRNA-143 expression is associated with the effects of antipsychotic drugs on phencyclidine-induced schizophrenia-related locomotor hyperactivity and with Neuregulin-1 expression in mice. | 2019 Oct | 1 |
11 | 28017790 | The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice. | 2017 Apr | 1 |
12 | 28186680 | The group II metabotropic glutamate receptor agonist LY354740 and the D2 receptor antagonist haloperidol reduce locomotor hyperactivity but fail to rescue spatial working memory in GluA1 knockout mice. | 2017 Apr | 1 |
13 | 29209205 | Potentiation of Morphine-Induced Antinociception by Propranolol: The Involvement of Dopamine and GABA Systems. | 2017 | 1 |
14 | 26706182 | Immunohistochemical evidence for the involvement of gonadotropin releasing hormone in neuroleptic and cataleptic effects of haloperidol in mice. | 2016 Apr | 1 |
15 | 26842661 | Haloperidol Suppresses NF-kappaB to Inhibit Lipopolysaccharide-Induced Pro-Inflammatory Response in RAW 264 Cells. | 2016 Feb 4 | 1 |
16 | 27435383 | Haloperidol aggravates transverse aortic constriction-induced heart failure via mitochondrial dysfunction. | 2016 Jul | 1 |
17 | 27480797 | Transcriptional dysregulation causes altered modulation of inhibition by haloperidol. | 2016 Dec | 1 |
18 | 27578530 | Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice. | 2016 Dec | 2 |
19 | 25826871 | [Effect of dopamine D1 and D2 receptor blockade on the immunostimulating effect of δ1 opioid receptor agonist DPDPE in mice with different psychoemotional states]. | 2015 | 1 |
20 | 26658842 | A behavioral defect of temporal association memory in mice that partly lack dopamine reuptake transporter. | 2015 Dec 10 | 1 |
21 | 24552586 | Quetiapine and aripiprazole signal differently to ERK, p90RSK and c-Fos in mouse frontal cortex and striatum: role of the EGF receptor. | 2014 Feb 20 | 1 |
22 | 24658464 | Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma. | 2014 Feb 28 | 1 |
23 | 24747358 | G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease. | 2014 Jul | 1 |
24 | 25122042 | Potentiation of latent inhibition by haloperidol and clozapine is attenuated in Dopamine D2 receptor (Drd-2)-deficient mice: do antipsychotics influence learning to ignore irrelevant stimuli via both Drd-2 and non-Drd-2 mechanisms? | 2014 Oct | 4 |
25 | 23385580 | Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels. | 2013 | 1 |
26 | 23422792 | D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors. | 2013 Jul | 1 |
27 | 23748226 | Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia. | 2013 Nov | 1 |
28 | 22561101 | Subunit-specific modulation of [(3)H]MK-801 binding to NMDA receptors mediated by dopamine receptor ligands in rodent brain. | 2012 Jul | 1 |
29 | 21062378 | Blocking dopamine D2 receptors by haloperidol curtails the beneficial impact of calorie restriction on the metabolic phenotype of high-fat diet induced obese mice. | 2011 Feb | 1 |
30 | 21603181 | Pharmacological modulation of dopamine receptor D2-mediated transmission alters the metabolic phenotype of diet induced obese and diet resistant C57Bl6 mice. | 2011 | 1 |
31 | 19963037 | The stimulatory effects of caffeine with oseltamivir (Tamiflu) on light-dark behavior and open-field behavior in mice. | 2010 Jan 22 | 1 |
32 | 20406627 | Involvement of dopamine receptors in the antidepressant-like effect of melatonin in the tail suspension test. | 2010 Jul 25 | 1 |
33 | 20618446 | Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. | 2010 Oct | 1 |
34 | 20720111 | Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. | 2010 Aug 18 | 1 |
35 | 20808911 | A transposon in Comt generates mRNA variants and causes widespread expression and behavioral differences among mice. | 2010 Aug 17 | 1 |
36 | 17696993 | Deficits in social behavior and sensorimotor gating in mice lacking phospholipase Cbeta1. | 2008 Feb | 1 |
37 | 18332675 | Dopamine-independent psychostimulant activity of a delta-agonist. | 2008 Mar | 1 |
38 | 18509028 | Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. | 2008 May 28 | 1 |
39 | 18690109 | Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. | 2008 Sep | 1 |
40 | 16336634 | Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. | 2006 Jan | 1 |
41 | 16407246 | Fyn is required for haloperidol-induced catalepsy in mice. | 2006 Mar 17 | 2 |
42 | 16563475 | Antinociceptive and behavioral effects of ribavirin in mice. | 2006 Feb | 1 |
43 | 16893530 | Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover. | 2006 Sep 15 | 1 |
44 | 16904653 | Acetylcholinesterase modulates stress-induced motor responses through catalytic and noncatalytic properties. | 2006 Oct 1 | 1 |
45 | 17029599 | Identification of a new functional target of haloperidol metabolite: implications for a receptor-independent role of 3-(4-fluorobenzoyl) propionic acid. | 2006 Oct | 1 |
46 | 17035544 | Dopaminergic control of sleep-wake states. | 2006 Oct 11 | 1 |
47 | 17097724 | Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction. | 2006 Nov | 1 |
48 | 15817666 | Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice. | 2005 Jul | 1 |
49 | 16284244 | A schizophrenia-related sensorimotor deficit links alpha 3-containing GABAA receptors to a dopamine hyperfunction. | 2005 Nov 22 | 1 |
50 | 15001689 | Dynamic imaging of striatal D2 receptors in mice using quad-HIDAC PET. | 2004 Mar | 1 |